FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3177235988> ?p ?o ?g. }

• W3177235988 endingPage "P" @default.
• W3177235988 startingPage "668" @default.
• W3177235988 abstract "Glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce body weight (BW). Evidence suggests that GLP-1RAs directly modulate appetite and reduce food intake through central mechanisms. However, GLP-1RAs are also associated with gastrointestinal (GI) adverse events (AEs), which may contribute to reduced appetite and food intake. We sought to assess whether the BW loss observed in phase 3 clinical trials with oral semaglutide was primarily due to indirect effects (defined as GI AEs, specifically nausea, vomiting, and diarrhea) or direct effects (not explained by GI AEs). Data from PIONEER 1-5, 7, and 8 were assessed and a mediation analysis (how a third variable [GI AEs] affects the relationship between two other variables [treatment and BW]) was performed to separate the overall contribution of direct and indirect effects to changes in BW. Significant total estimated treatment differences in BW loss were observed vs. all comparators with oral semaglutide 7 mg (1.0-3.7 kg vs. placebo, 1.7 kg vs. active comparator) and 14 mg (2.7-5.0 kg vs. placebo, 0.8-2.4 kg vs. active comparators). In the mediation analysis, GI AEs accounted for 0.0-0.3 kg of the BW loss across oral semaglutide doses vs. all comparators (Figure). In conclusion, GI AEs (indirect effects) appear to have no clinically relevant impact on total BW loss observed with oral semaglutide vs. placebo and most active comparators. Disclosure J. J. Meier: Advisory Panel; Self; AstraZeneca, MSD Corporation, Novo Nordisk, Speaker’s Bureau; Self; AstraZeneca, Boehringer Ingelheim International GmbH, Lilly Diabetes, MSD Corporation, Novo Nordisk, Sanofi. R. Agesen: Employee; Self; Novo Nordisk. L. Bardtrum: Employee; Self; Novo Nordisk A/S, Stock/Shareholder; Self; Novo Nordisk A/S. A. Y. Cheng: Advisory Panel; Self; Abbott, AstraZeneca, Bayer Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, HLS Therapeutics Inc., Janssen Pharmaceuticals, Inc., Medtronic, Merck & Co., Inc., Merck Sharp & Dohme Corp., Novo Nordisk, Sanofi, Research Support; Self; Applied Therapeutics, The Medicine Company, Speaker’s Bureau; Self; Abbott, AstraZeneca, Bausch Health, Canada, Bayer Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, HLS Therapeutics Inc., Janssen Pharmaceuticals, Inc., Medtronic, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk, Sanofi. S. Deenadayalan: Employee; Self; Novo Nordisk A/S, Stock/Shareholder; Self; Novo Nordisk A/S. E. Montanya: Advisory Panel; Self; Sanofi, Consultant; Self; Merck Sharp & Dohme Corp., Employee; Spouse/Partner; Almirall, S. A., Research Support; Self; Menarini Group, Roche Diagnostics SL, Speaker’s Bureau; Self; Novo Nordisk A/S. R. E. Pratley: Other Relationship; Self; Hanmi Pharmaceutical, Merck Sharp & Dohme Corp., Metavention, Monster Energy Company, Inc., Novo Nordisk, Pfizer Inc., Poxel SA, Sanofi, Scohia Pharma Inc., Sun Pharmaceutical Industries Ltd. Funding Novo Nordisk A/S" @default.
• W3177235988 created "2021-07-05" @default.
• W3177235988 creator A5002832666 @default.
• W3177235988 creator A5011764644 @default.
• W3177235988 creator A5014306017 @default.
• W3177235988 creator A5023695680 @default.
• W3177235988 creator A5031060251 @default.
• W3177235988 creator A5050647076 @default.
• W3177235988 creator A5059098934 @default.
• W3177235988 date "2021-06-01" @default.
• W3177235988 modified "2023-09-27" @default.
• W3177235988 title "668-P: Body Weight Loss with Oral Semaglutide Is Predominantly Mediated by Effects Other than Gastrointestinal Adverse Events" @default.
• W3177235988 doi "https://doi.org/10.2337/db21-668-p" @default.
• W3177235988 hasPublicationYear "2021" @default.
• W3177235988 type Work @default.
• W3177235988 sameAs 3177235988 @default.
• W3177235988 citedByCount "0" @default.
• W3177235988 crossrefType "journal-article" @default.
• W3177235988 hasAuthorship W3177235988A5002832666 @default.
• W3177235988 hasAuthorship W3177235988A5011764644 @default.
• W3177235988 hasAuthorship W3177235988A5014306017 @default.
• W3177235988 hasAuthorship W3177235988A5023695680 @default.
• W3177235988 hasAuthorship W3177235988A5031060251 @default.
• W3177235988 hasAuthorship W3177235988A5050647076 @default.
• W3177235988 hasAuthorship W3177235988A5059098934 @default.
• W3177235988 hasConcept C126322002 @default.
• W3177235988 hasConcept C134018914 @default.
• W3177235988 hasConcept C147583825 @default.
• W3177235988 hasConcept C197934379 @default.
• W3177235988 hasConcept C2777180221 @default.
• W3177235988 hasConcept C2781308992 @default.
• W3177235988 hasConcept C2909862629 @default.
• W3177235988 hasConcept C511355011 @default.
• W3177235988 hasConcept C544821477 @default.
• W3177235988 hasConcept C555293320 @default.
• W3177235988 hasConcept C71924100 @default.
• W3177235988 hasConceptScore W3177235988C126322002 @default.
• W3177235988 hasConceptScore W3177235988C134018914 @default.
• W3177235988 hasConceptScore W3177235988C147583825 @default.
• W3177235988 hasConceptScore W3177235988C197934379 @default.
• W3177235988 hasConceptScore W3177235988C2777180221 @default.
• W3177235988 hasConceptScore W3177235988C2781308992 @default.
• W3177235988 hasConceptScore W3177235988C2909862629 @default.
• W3177235988 hasConceptScore W3177235988C511355011 @default.
• W3177235988 hasConceptScore W3177235988C544821477 @default.
• W3177235988 hasConceptScore W3177235988C555293320 @default.
• W3177235988 hasConceptScore W3177235988C71924100 @default.
• W3177235988 hasIssue "Supplement 1" @default.
• W3177235988 hasLocation W31772359881 @default.
• W3177235988 hasOpenAccess W3177235988 @default.
• W3177235988 hasPrimaryLocation W31772359881 @default.
• W3177235988 hasRelatedWork W1987327892 @default.
• W3177235988 hasRelatedWork W2013644072 @default.
• W3177235988 hasRelatedWork W2014830377 @default.
• W3177235988 hasRelatedWork W2063052824 @default.
• W3177235988 hasRelatedWork W2136570648 @default.
• W3177235988 hasRelatedWork W2254297168 @default.
• W3177235988 hasRelatedWork W2323348854 @default.
• W3177235988 hasRelatedWork W2437243933 @default.
• W3177235988 hasRelatedWork W3212875906 @default.
• W3177235988 hasRelatedWork W4254620922 @default.
• W3177235988 hasVolume "70" @default.
• W3177235988 isParatext "false" @default.
• W3177235988 isRetracted "false" @default.
• W3177235988 magId "3177235988" @default.
• W3177235988 workType "article" @default.